This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

The UK Department of Health, Reckitt Benckiser settle on Gaviscon claim

( February 28, 2014, 15:00 GMT | Official Statement) -- MLex Summary: The UK's Department of Health and drug maker Reckitt Benckiser announced that they have reached a settlement agreement on the claim brought against Reckitt in connection with the supply of heartburn drug Gaviscon to the NHS in England. Under the terms of the settlement, Reckitt has agreed to make a payment to the Department of Health on a "full and final basis and without admission of liability."The full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections